ABSTRACT

KEYWORDS

REFERENCES

1. Vázquez-García JC. Cursos de espirometría ALAT. 2013. Fecha de consulta: 14-VI-2016. Accesible en: http://www. congresosalat.org/images/stories/3_pdf/cursos_ALAT/ espirometria/programa_cursosespirometriaALAT.pdf

2. NIOSH. Existing spirometry NIOSH-aproved courses. Access date: 2016 June 15. Available from: http://www. cdc.gov/niosh/topics/spirometry/approved-course.html

3. Pérez-Padilla R, Valdivia G, Muiño A, et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol 2006;42(7):317-325.

4. Pérez-Padilla R, Vázquez-García JC, Márquez MN, et al; Latin American COPD Prevalence Study (PLATINO) Team. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2006;51(10):1167-1171.

5. Pérez-Padilla R, Bouscoulet LT, Vázquez-García JC, et al; PLATINO Group. Spirometry reference values after inhalation of 200 microg of salbutamol. Arch Bronconeumol 2007;43(10):530-534.

6. Pérez-Padilla R, Hallal PC, Vázquez-García JC, et al; PLATINO Group. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007;4(2):113-120.

7. Pérez-Padilla R, Vázquez-García JC, Márquez MN, Menezes AM; PLATINO Group. Spirometry qualitycontrol strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2008;53(8):1019-1026.

8. Vázquez-García JC, Pérez-Padilla J. Manual para el uso y la interpretación de la espirometría por el médico. Asociación Latinoamericana del Tórax; 2007. pp.76.

9. ALAT. Cursos fisiopatología ALAT. Access date: 2016 June 16. Available from: https://http://www.alatorax. org/fisiopatologia/cursos-fisiopatologia-alat

10. Vargas-Domínguez C, Gochicoa-Rangel L, Velázquez- Uncal M, et al. Pruebas de función respiratoria, ¿cuál y a quién? Neumol Cir Torax 2011;70(2):101-117.

11. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347- 365. doi: 10.1164/rccm.201204-0596PP.

12. Tálamo C, de Oca MM, Halbert R, et al; PLATINO Team. Diagnostic labeling of COPD in five Latin American cities. Chest 2007;131(1):60-67.

13. Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015;46(3):622-639. doi: 10.1183/13993003.00853- 2015.